Global Bioenergies's small IPO: Size is not what matters
July 28, 2011 | Analyst Insight
Global Bioenergies recently went public on the NYSE Euronext, taking in €6.6 million (about $9 million) for a valuation of about $56 million. The company has developed a microorganism capable of excreting isobutene, an...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.